Skip to main content

DNA X, Inc.

SONM
Exchange
Nasdaq
Industry
Telephone & Telegraph Apparatus
SEC CIK
0001178697

No open-market purchases or sales by DNA X, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $453.8K in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding DNA X, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of SONM: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders1517+2
Shares558.7K2.17M+1.61M (+288.4%)
Value$1.51M$2.00M+$491.0K (+32.6%)

New holders (8)

Institutions that held DNA X, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to SONM in Q4 2021
InstitutionSharesValue% of portfolio
Quadrature Capital Ltd121,489$112.0K0.01%
Renaissance Technologies LLC112,034$103.0K0.00%
Credit Suisse AG60,000$55.0K0.00%
Virtu Financial LLC51,518$47.0K0.00%
Two Sigma Securities, LLC42,062$39.0K0.01%
Susquehanna International Group, LLP29,449$27.0K0.00%
Two Sigma Advisers, LP21,100$19.0K0.00%
Citigroup Inc14,860$14.0K0.00%

Sold out (6)

Institutions that held DNA X, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of SONM in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Bank of New York Mellon Corp22,671$61.0K
Dynamic Advisor Solutions LLC11,911$32.0K
UBS Group AG1,629$4.00K
Harbour Investments, Inc.200$1.00K
JPMorgan Chase & Co12$0
Meeder Asset Management Inc82$0